Showing results (51-60 of 210) with videos related to

Sort By:
Pageof 21
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|July 23, 2025
Value of Spectral CT Techniques for the Assessment of Bone Marrow Infiltration in Multiple Myeloma: A Systematic Literature ReviewYasmin Fede Melzer, Jennifer Erley, Inka Ristow, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 1, 2023
Predictors of Lenalidomide Refractory Relapse Timing With Newly Diagnosed Multiple Myeloma: A FIRST Trial SubanalysisSalomon Manier, Meletios Dimopoulos, Cyrille Hulin, et al.
British Journal of Haematology|July 20, 2024
Multiple myeloma refractory to lenalidomide: A systematic literature review of trials and real-world evidenceMonique A Hartley-Brown, Katja Weisel, Jacopo Bitetti, et al.
Cancers|December 23, 2023
Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical TrialsEdward Laane, Sam Salek, Esther Natalie Oliva, et al.
Leukemia & Lymphoma|February 12, 2024
Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparisonKatja Weisel, Meletios A Dimopoulos, Meral Beksac, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|April 26, 2025
Changes in sagittal spinopelvic alignment are associated with increased pain and impaired function in multiple myeloma patientsJulian Kylies, Michael Dirks, Elias Brauneck, et al.
Annals of Hematology|June 18, 2026
Infectious toxicities associated with bispecific antibodies and CAR-T Cells in multiple myeloma: a systematic reviewMagdalena Benda, Patrick Reimann, Wolfgang Willenbacher, et al.
Blood Cancer Journal|February 24, 2019
Health-related quality of life in the ENDEAVOR study: carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myelomaHeinz Ludwig, Philippe Moreau, Meletios A Dimopoulos, et al.
Bone Marrow Transplantation|May 13, 2026
Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myelomaLeo Rasche, Maria Theresa Krauth, Hermine Agis, et al.
Blood Advances|May 10, 2023
Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR studySaad Z Usmani, Hang Quach, Maria-Victoria Mateos, et al.
Pageof 21